Industry News: New Keynote Speaker Added to SBS 2011

24 Nov 2010

SBS 2011 announces that a third influential, engaging keynote speaker has been added to the line-up.

Hugh Rosen, M.D., Ph.D.,
The Scripps Research Institute
Allostery and S1P Receptors: A Syzygy of Pharmacology and High-Resolution Crystal Structure
• Robert J. Lefkowitz, M.D.,
Duke University School of Medicine, Durham, North Carolina
Beta Arrestin Mediated Signaling by 7 Transmembrane Receptors: New Therapeutic Opportunities
• Brian Shoichet, Ph.D.,
University of California, San Francisco
Mechanism and Effects of Colloidal Aggregation in Early Discovery and Drug Pharmacology

Enriching Short Course Program Offers
Short Courses offer a rapid introduction to or relevant refresher on important Drug Discovery topics. Led by distinguished faculty with deep expertise in their respective course topic, SBS short courses offer practical training and a great opportunity to network with short course colleagues.

SBS 2011 Participants Encouraged to Participate in Special Interest Groups (SIGs)
There is no fee to attend SIG meetings, but pre-registration is recommended, as space is limited.
• Academic Outreach
• Automation Quality Control
• Data and Image Analysis
• Drug Repositioning
• Microplate Standards
• Sample Management
• Screen Design and Assay Technology
• Stem Cells
Early-Bird Registration Discount
When you register on or before January 24, 2011 you can save up to $200 on conference registration – so register today and save!

Follow the Company article page link top right of this page to register.